Drug · DIN 02451034
KYPROLIS
FOR I.V. INFUSION. SINGLE-USE VIAL
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since February 11, 2016; first marketed February 11, 2016.
- Drug Identification Number (DIN)
- 02451034
- Company (DIN owner)
- Amgen Canada IncMississauga, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Powder For Solution
- Route
- Intravenous
- Therapeutic class (ATC)
- Carfilzomib L01XG02
- Class
- Human
- Record last updated
- August 13, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| CARFILZOMIB | 60 MG | VIAL |
Notices of Compliance
Health Canada approvals that name this DIN.
- January 15, 2016: NOC 17669New Drug Submission (NDS)
Other DINs named KYPROLIS
- DIN 02459930 · Marketed
- DIN 02459949 · Marketed